US Physical Therapy (USPH) Tops Q2 EPS by 25c; Raises Outlook

US Physical Therapy (NYSE: USPH) reported Q2 EPS of $0.96, $0.25 better than the analyst estimate of $0.71. Revenue for the quarter came in at $126.93 million versus the consensus estimate of $121.35 million.

GUIDANCE:

Management increased its range of earnings guidance for full year 2021 to Operating Results per share of $3.05 to $3.15 from the previous range of $2.68 to $2.78 due to the Company’s strong performance in the 2021 Second Quarter, the impact of the acquisition closed in the 2021 Second Quarter an

For earnings history and earnings-related data on US Physical Therapy (USPH) click here.

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
• Pfizer's 25-valent pneumococcal vaccine shows Phase 2 results